Abstract | AIMS: METHODS: Matched tissue and plasma samples were collected from patients with advanced non-small cell lung cancer (NSCLC) (stage IIIB/IV adenocarcinoma/ adenosquamous carcinoma), with matched MPE samples collected from a subgroup. DNA was extracted from tissue, MPE cell block, MPE supernatant and plasma before mutation detection by amplification refractory mutation system (ARMS) (all samples), Sanger sequencing and mutant-specific immunohistochemistry (IHC) (tissue and MPE cell blocks only). RESULTS: Sensitivity of MPE cell block, MPE supernatant and plasma versus tissue: 81.8% (9/11), 63.6% (7/11) and 67.5% (27/40); specificity was 80.0% (8/10), 100% (10/10) and 100% (46/46), respectively. Sensitivity of Sanger sequencing versus ARMS: 81.8% (27/33) for tissue, 40% (4/10) for MPE cell blocks; specificity was 100% (36/36 and 12/12) for both. Sensitivity of mutant-specific IHC versus ARMS: 54.8% (17/31) for tissue, 50.0% (6/12) for MPE cell blocks; specificity was 97.1% (34/35) and 100% (14/14), respectively. CONCLUSIONS: MPE and plasma are valid surrogates for NSCLC tumour EGFR mutation detection when tissue is not available. ARMS is most suitable for mutation detection in tissue and MPE cell blocks; however, mutant-specific IHC could be a complementary method when DNA-based molecular testing is unavailable.
|
Authors | Xiaoqing Liu, Yachao Lu, Guanshan Zhu, Yao Lei, Li Zheng, Haifeng Qin, Chuanhao Tang, Gillian Ellison, Rose McCormack, Qunsheng Ji |
Journal | Journal of clinical pathology
(J Clin Pathol)
Vol. 66
Issue 12
Pg. 1065-9
(Dec 2013)
ISSN: 1472-4146 [Electronic] England |
PMID | 23888061
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Neoplasm
- ErbB Receptors
|
Topics |
- Adenocarcinoma
(genetics, metabolism, pathology)
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Adenosquamous
(genetics, metabolism, pathology)
- Carcinoma, Non-Small-Cell Lung
(genetics, metabolism, pathology)
- China
- DNA, Neoplasm
(chemistry, genetics)
- ErbB Receptors
(genetics, metabolism)
- Female
- Humans
- Immunohistochemistry
- Lung Neoplasms
(genetics, metabolism, pathology)
- Male
- Middle Aged
- Mutation
- Plasma
- Pleural Effusion, Malignant
(genetics, metabolism, pathology)
- Sensitivity and Specificity
- Sequence Analysis, DNA
|